NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20263 | Giredestrant tartrate | 2407529-33-1 | ≧98.0% |  |
| Giredestrant tartrate (GDC-9545 tartrate), a non-steroidal ER ligand, is an orally ac | ||||
| 20265 | Daridorexant ( ACT541468 ) | 1505484-82-1 | ≧98.0% | _1505484-82-1.gif) |
| Daridorexant is a dual orexin receptor antagonist (DORA) designed and developed for t | ||||
| 21922 | Difelikefalin HCl | 2413256-25-2 | ≧98.0% |  |
| Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is a novel and potent kappa opio | ||||
| 20278 | PD-159206 | 171744-42-6 | ≧94.0% |  |
| PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HI | ||||
| 20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% |  |
| Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
| 20300 | Acoramidis (AG-10 ) | 1446711-81-4 | ≧98.0% |  |
| Acoramidis (formerly AG10) is an investigational, orally-administered small molecule | ||||
| 20302 | VAS3947 | 869853-70-3 | ≧98.0% |  |
| VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentr | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little b | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||